NIH Reporter #1ZIAAI001081-16

International Tuberculosis Clinical Research Solicitation by NIAID

NIAID, part of the NIH, is seeking proposals for international tuberculosis clinical research. - Government Buyer: - National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) - Scope of Work: - Conduct biomarker research, drug development, and clinical trials related to tuberculosis - Develop diagnostics, therapeutics, and treatment strategies for tuberculosis - Collaborate with international partners, including locations in South Africa and China - Products/Services Requested: - Research services covering biomarker studies, drug development, clinical trials, and development of diagnostics and therapeutics - OEMs and Vendors: - No specific OEMs or vendors are mentioned - Unique Requirements: - Emphasis on international collaboration and multi-site research - Estimated Funding: - Approximately $487,751

Description

This project involves multiple studies related to tuberculosis, including biomarker research, drug development, and clinical trials. The scope includes developing diagnostics, therapeutics, and treatment strategies for tuberculosis. It is conducted by the National Institute of Allergy and Infectious Diseases (NIAID) with collaborations involving international partners. The total funding amount is approximately $487,751 for FY 2025.

View original listing